首页> 美国卫生研究院文献>BMJ Open >Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat) a phase IV single-arm open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C

【2h】

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat) a phase IV single-arm open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C

机译：消除阿巴拉契亚县农村丙型肝炎：肯塔基病毒性肝炎治疗研究（关键治疗）第四阶段单臂Sofosbuvir / Velpatasvir用于治疗丙型肝炎的第IV阶段单臂开放标签试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The overall goal of the Kentucky Viral Hepatitis Treatment Study (KeY Treat) is to eliminate hepatitis C transmission from a county in Appalachian Kentucky by removing the barriers to accessing hepatitis C virus (HCV) treatment.

机译：肯塔基病毒性肝炎治疗研究（关键治疗）的总体目标是通过去除丙型肝炎病毒（HCV）治疗的障碍来消除阿巴拉契亚肯塔基州的一个县的丙型肝炎传播。

著录项

期刊名称 BMJ Open
作者
Jennifer R Havens; Takako Schaninger; Hannah Fraser; Michelle Lofwall; Michele Staton; April M Young; Ardis Hoven; Sharon L Walsh; Peter Vickerman;
展开▼
作者单位

展开▼
年(卷),期 2021(11),7
年度 2021
页码 e041490
总页数 9
原文格式 PDF
正文语种
中图分类
关键词

机译：流行病学;公共卫生;肝脏学;
入库时间 2022-08-21 12:32:00

相似文献

外文文献
中文文献
专利

1. Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study [J] . Wyles David, Brau Norbert, Kottilil Shyam, Clinical infectious diseases . 2017,第1期

机译：Sofosbuvir和Velpatasvir用于治疗患有人免疫缺陷病毒的患者乙型肝炎病毒1型：开放标签，第3期研究
2. LBP‐005: Efficacy and safety of Sofosbuvir/Velpatasvir for the treatment of treatment‐na?ve, non‐cirrhotic patients with chronic hepatitis C genotype 3 infection: integrated analysis of three phase 3 clinical trials [J] . Journal of viral hepatitis. . 2018,第S1期

机译：LBP-005：Sofosbuvir / VelpataSvir用于治疗治疗 - na've，非肝硬化患者的慢性丙型肝炎患者的疗效和安全性3感染：三期3阶段临床试验的综合分析
3. French Hepatitis C (HCV) Patients Treated with Anti-viral Combinations Containing Pegylated Interferon (IFN), Ribavirin (RBV), Sofosbuvir (SOF), Ledipasvir (LDV), Velpatasvir (VEL) and/or Voxilaprevir (VOX): The Impact of Treatment on Patient-Reported Outcomes (PROs) [J] . Cacoub Patrice P., Bourliere Marc, Asselah Tarik, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：法国丙型肝炎（HCV）含有聚乙二醇干扰素（IFN），利巴韦林（RBV），Sofosbuvir（SOF），LEDIPASVIR（LDV），VELPATASVIR（VEL）和/或VoxILAPREVIR（VOX）的抗病毒组合患者：影响对患者报告的结果（专业）的治疗
4. DYNAMICS OF HEPATITIS C VIRAL LOAD WITH OPTIMAL CONTROL TREATMENT STRATEGY [C] . RAM KEVAL, SANDIP BANERJEE International Symposium on Mathematical and Computational Biology . 2017

机译：丙型肝炎病毒载荷的动态与最优控制处理策略
5. Viral Vaccine Vectors for the Treatment of Chronic Hepatitis B Virus Infection. [D] . Reynolds, Tracy Dawn. 2015

机译：用于治疗慢性乙型肝炎病毒感染的病毒疫苗载体。
6. Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label Phase 3 Study [O] . David Wyles, Norbert Bräu, Shyam Kottilil, -1

机译：Sofosbuvir和Velpatasvir用于治疗人类免疫缺陷病毒1型共感染患者的丙型肝炎病毒：一项开放标签的3期研究
7. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY):an open-label, single-arm, phase 4, multicentre trial [O] . Grebely, Jason, Dalgard, Olav, Conway, Brian, 2018

机译：Sofosbuvir和velpatasvir用于近期注射吸毒者的丙型肝炎病毒感染（SIMPLIFY）：开放标签，单臂，4期，多中心试验
8. Combating the Silent Epidemic of Viral Hepatitis. Action Plan for the Prevention, Care and Treatment of Viral Hepatitis. [R] . 2012

机译：打击病毒性肝炎的无声流行。预防，护理和治疗病毒性肝炎行动计划。

Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat) a phase IV single-arm open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C

摘要

著录项

相似文献

相关主题

期刊订阅